OpGen Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
John Tan
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | less than a year |
Board average tenure | less than a year |
Recent management updates
Recent updates
OpGen to raise $3.38M in direct stock offering
Sep 30OpGen's subsidiary signs R&D agreement with FIND
Sep 20Nasdaq grants extension to OpGen to regain compliance with minimum bid price requirement
Aug 31OpGen launches sequencing services for infectious diseases in US
Aug 25OpGen GAAP EPS of -$0.13 beats by $0.02, revenue of $1M in-line
Aug 11OpGen reports preliminary revenue estimate for Q2 2022
Jul 08OpGen gains on insider buying
Jun 15OpGen submits 510(k) summary to FDA for Acuitas AMR Gene Panel for Isolates
Jun 07OpGen reports prelim Q4 & FY20 revenue
Jan 13OpGen subsidiary Curetis and Annar ink Unyvero distribution partnership for Colombia
Jan 05OpGen launches $10M private placement
Nov 24OpGen EPS misses by $0.04, beats on revenue
Nov 11OpGen's subsidiary and collaborators secures German funding to develop such a molecular diagnostics platform
Oct 28CEO
John Tan (34 yo)
less than a year
Tenure
Mr. Honjian Tan, also known as John, is Chief Executive Officer & Chairman of OpGen, Inc. from August 2, 2024. Mr. Tan is President, Chief Executive Officer, CFO, Secretary & Chairman of UBuyHoldings, Inc....
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive VP of Corporate Development | less than a year | US$364.48k | no data | |
CEO & Chairman | less than a year | no data | no data | |
President | less than a year | no data | 0.099% $ 7.2k | |
Corporate Controller | less than a year | no data | no data | |
Chief Operating Officer | no data | no data | no data | |
Company Secretary | no data | no data | no data |
0.5yrs
Average Tenure
34yo
Average Age
Experienced Management: OPGN's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | less than a year | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data | |
Member of Clinical Advisory Board | 8.8yrs | no data | no data | |
Member of Clinical Advisory Board | 8.8yrs | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data | |
Independent Director | less than a year | no data | no data | |
Director | less than a year | no data | no data | |
Director | less than a year | no data | no data |
0.3yrs
Average Tenure
34.5yo
Average Age
Experienced Board: OPGN's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 23:19 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
OpGen, Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Benjamin Haynor | Alliance Global Partners |
null null | Brookline Capital Markets |
Nidhi Singh | Edison Investment Research |